Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer
Dosimetry is critical to achieve the optimal therapeutic effect of radioligand therapy (RLT) with limited side effects. Our aim was to perform image-based absorbed dose calculation for the new PSMA ligand 177Lu-DKFZ-PSMA-617 in support of its use for the treatment of metastatic prostate cancer.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2016
|
| In: |
European journal of nuclear medicine and molecular imaging
Year: 2015, Jahrgang: 43, Heft: 1, Pages: 42-51 |
| ISSN: | 1619-7089 |
| DOI: | 10.1007/s00259-015-3174-7 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00259-015-3174-7
|
| Verfasserangaben: | Andreas Delker, Wolfgang Peter Fendler, Clemens Kratochwil, Anika Brunegraf, Astrid Gosewisch, Franz Josef Gildehaus, Stefan Tritschler, Christian Georg Stief, Klaus Kopka, Uwe Haberkorn, Peter Bartenstein and Guido Böning |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1697649998 | ||
| 003 | DE-627 | ||
| 005 | 20230427190239.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200507r20162015xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00259-015-3174-7 |2 doi | |
| 035 | |a (DE-627)1697649998 | ||
| 035 | |a (DE-599)KXP1697649998 | ||
| 035 | |a (OCoLC)1341319172 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Delker, Andreas |e VerfasserIn |0 (DE-588)1112046372 |0 (DE-627)866029699 |0 (DE-576)476342554 |4 aut | |
| 245 | 1 | 0 | |a Dosimetry for 177Lu-DKFZ-PSMA-617 |b a new radiopharmaceutical for the treatment of metastatic prostate cancer |c Andreas Delker, Wolfgang Peter Fendler, Clemens Kratochwil, Anika Brunegraf, Astrid Gosewisch, Franz Josef Gildehaus, Stefan Tritschler, Christian Georg Stief, Klaus Kopka, Uwe Haberkorn, Peter Bartenstein and Guido Böning |
| 264 | 1 | |c 2016 | |
| 300 | |a 10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 07.05.2020 | ||
| 520 | |a Dosimetry is critical to achieve the optimal therapeutic effect of radioligand therapy (RLT) with limited side effects. Our aim was to perform image-based absorbed dose calculation for the new PSMA ligand 177Lu-DKFZ-PSMA-617 in support of its use for the treatment of metastatic prostate cancer. | ||
| 534 | |c 2015 | ||
| 700 | 1 | |a Fendler, Wolfgang Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kratochwil, Clemens |d 1978- |e VerfasserIn |0 (DE-588)134026276 |0 (DE-627)559871686 |0 (DE-576)300262787 |4 aut | |
| 700 | 1 | |a Brunegraf, Anika |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gosewisch, Astrid |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gildehaus, Franz Josef |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tritschler, Stefan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Stief, Christian Georg |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kopka, Klaus |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haberkorn, Uwe |d 1959- |e VerfasserIn |0 (DE-588)1022913905 |0 (DE-627)717331245 |0 (DE-576)366166352 |4 aut | |
| 700 | 1 | |a Bartenstein, Peter |e VerfasserIn |4 aut | |
| 700 | 1 | |a Böning, Guido |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of nuclear medicine and molecular imaging |d Heidelberg [u.a.] : Springer-Verl., 2002 |g 43(2016), 1, Seite 42-51 |h Online-Ressource |w (DE-627)359787258 |w (DE-600)2098375-X |w (DE-576)110279549 |x 1619-7089 |7 nnas |a Dosimetry for 177Lu-DKFZ-PSMA-617 a new radiopharmaceutical for the treatment of metastatic prostate cancer |
| 773 | 1 | 8 | |g volume:43 |g year:2016 |g number:1 |g pages:42-51 |g extent:10 |a Dosimetry for 177Lu-DKFZ-PSMA-617 a new radiopharmaceutical for the treatment of metastatic prostate cancer |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00259-015-3174-7 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200507 | ||
| 993 | |a Article | ||
| 994 | |a 2016 | ||
| 998 | |g 1022913905 |a Haberkorn, Uwe |m 1022913905:Haberkorn, Uwe |d 910000 |d 911400 |e 910000PH1022913905 |e 911400PH1022913905 |k 0/910000/ |k 1/910000/911400/ |p 10 | ||
| 998 | |g 134026276 |a Kratochwil, Clemens |m 134026276:Kratochwil, Clemens |d 910000 |d 911400 |e 910000PK134026276 |e 911400PK134026276 |k 0/910000/ |k 1/910000/911400/ |p 3 | ||
| 999 | |a KXP-PPN1697649998 |e 3662178559 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title_sort":"Dosimetry for 177Lu-DKFZ-PSMA-617","subtitle":"a new radiopharmaceutical for the treatment of metastatic prostate cancer","title":"Dosimetry for 177Lu-DKFZ-PSMA-617"}],"language":["eng"],"person":[{"role":"aut","family":"Delker","given":"Andreas","display":"Delker, Andreas"},{"given":"Wolfgang Peter","display":"Fendler, Wolfgang Peter","family":"Fendler","role":"aut"},{"given":"Clemens","display":"Kratochwil, Clemens","family":"Kratochwil","role":"aut"},{"family":"Brunegraf","display":"Brunegraf, Anika","given":"Anika","role":"aut"},{"role":"aut","family":"Gosewisch","given":"Astrid","display":"Gosewisch, Astrid"},{"given":"Franz Josef","display":"Gildehaus, Franz Josef","family":"Gildehaus","role":"aut"},{"given":"Stefan","display":"Tritschler, Stefan","family":"Tritschler","role":"aut"},{"given":"Christian Georg","display":"Stief, Christian Georg","family":"Stief","role":"aut"},{"family":"Kopka","given":"Klaus","display":"Kopka, Klaus","role":"aut"},{"role":"aut","family":"Haberkorn","given":"Uwe","display":"Haberkorn, Uwe"},{"display":"Bartenstein, Peter","given":"Peter","family":"Bartenstein","role":"aut"},{"role":"aut","display":"Böning, Guido","given":"Guido","family":"Böning"}],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"2016"}],"name":{"displayForm":["Andreas Delker, Wolfgang Peter Fendler, Clemens Kratochwil, Anika Brunegraf, Astrid Gosewisch, Franz Josef Gildehaus, Stefan Tritschler, Christian Georg Stief, Klaus Kopka, Uwe Haberkorn, Peter Bartenstein and Guido Böning"]},"recId":"1697649998","note":["Gesehen am 07.05.2020"],"relHost":[{"recId":"359787258","disp":"Dosimetry for 177Lu-DKFZ-PSMA-617 a new radiopharmaceutical for the treatment of metastatic prostate cancerEuropean journal of nuclear medicine and molecular imaging","language":["eng"],"pubHistory":["29.2002 -"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedDisp":"2002-","publisher":"Springer-Verl.","publisherPlace":"Heidelberg [u.a.]","dateIssuedKey":"2002"}],"title":[{"title":"European journal of nuclear medicine and molecular imaging","title_sort":"European journal of nuclear medicine and molecular imaging","subtitle":"official journal of the European Association of Nuclear Medicine (EANM)"}],"id":{"eki":["359787258"],"zdb":["2098375-X"],"issn":["1619-7089"]},"part":{"extent":"10","issue":"1","year":"2016","pages":"42-51","text":"43(2016), 1, Seite 42-51","volume":"43"},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 13.02.2023","Ungezählte Beil.: Supplement"]}],"physDesc":[{"extent":"10 S."}],"id":{"doi":["10.1007/s00259-015-3174-7"],"eki":["1697649998"]},"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a DELKERANDRDOSIMETRYF2016 | ||